Active-ingredient Dossier
Palonosetron Hydrochloride
Active-ingredient Dossier for Palonosetron Hydrochloride (5-ht3 antagonist). Australian brands, products, PBS listings, PBAC outcomes — compiled by…
- Brand: ALOXI
- Brand: PALOCIP
- Brand: PALONOSETRON
- Brand: PALONOSETRON
- Brand: APO-PALONOSETRON
- Brand: PALONOSETRON
- Therapeutic area: Oncology
What is
Palonosetron Hydrochloride Palonosetron Hydrochloride is a 5-HT3 antagonist.
Australian brands containing
Palonosetron Hydrochloride — ALOXI — PALOCIP — APO-PALONOSETRON — PALONOSET — PALSET
Therapeutic areas
Palonosetron Hydrochloride is registered in oncology, with 10 brands containing this ingredient on the ARTG.
Sponsor landscape
The ingredient is marketed by six sponsors: Dr Reddys Laboratories, Juno Pharmaceuticals, Cipla, Juniper Biologics, Medsurge Pharma, and Baxter Healthcare.
PBS and regulatory activity
One brand containing palonosetron hydrochloride has PBS-listed items, with the latest PBS schedule dated 1 May 2026. The latest PBAC outcome is from 1 March 2010 and the latest AusPAR is from 20 August 2013.